Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX  
2.03
-0.06 (-2.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)297.07M
Current PEN/A
Forward PE 2.94
2yr Forward PE 2.45
See more stats
Estimates Current Quarter
Revenue$562.47 Million
Adjusted EPS$0.18
See more estimates
10-Day MA$2.12
50-Day MA$2.68
200-Day MA$3.68
See more pivots

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Stock, NYSE:AMRX

400 Crossing Boulevard, 3rd floor, Bridgewater, New Jersey 08807
United States of America
Phone: +1.908.947.3120
Number of Employees: 7000

Description

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.